How many new companies were registered in 2026?

So far in 2026, 12 new companies with PKD 21 have been registered. In all of 2025, there were 27 such companies.

How many companies were deregistered in 2026?

So far in 2026, 4 companies with PKD 21 have been deregistered. In all of 2025, there were 32 such companies.

What revenue do companies in PKD division 21 generate?

In 2025, the median revenue for PKD 21 was USD 975.51k and the mean revenue was USD 26.74m, based on 248 financial statements. Averages and medians include only companies that file financial statements, excluding sole proprietorships.

Are companies in PKD division 21 profitable?

Yes, in 2025, the median net profit was USD 26.40k, an improvement on 2024 (USD 7.75k). Among all 678 PKD divisions in Poland, it ranks 358th, placing it among the weakest 47%.

What legal form do companies in PKD division 21 take?

The most common legal form for PKD 21 is sp. z o.o., used by 1,183 companies in this industry (68.6% of the total). In second place is sp. j. (228 companies, 13.2%), and in third place – S.A. (100 companies, 5.8%).

Manufacture of basic pharmaceutical products and pharmaceutical preparations (PKD division 21)

Q: How many companies operate in PKD division 21?

The primary industry for 941 companies is manufacture of basic pharmaceutical products and pharmaceutical preparations. 424 entities have filed financial statements.

This division includes:

the production of basic pharmaceutical substances,
the production of medicines, including homeopathic preparations,
the production of other pharmaceutical products.

Industry statistics (2025)

Number of companies

Companies

9,003

Companies (primary PKD)

941

Companies with financials

424

Business turnover

Legal structure

Legal formShare of companiesNumber of companies

Sp. z o.o.68.6%1,183
Sp. j.13.2%228
S.A.5.8%100
JDG3.8%66
Sp. k.2.5%43
Cooperative2.0%34
Other1.4%25
Foundation0.9%15
P.S.A.0.7%12
Association0.6%10

Financial results

Median revenue

Ranking

Median revenue compared with other PKD codes.

Top companies by revenue

#	Company	Legal form	Revenue	Net profit
1	Zakłady Farmaceutyczne Polpharma	S.A.	USD 1.36bn	USD 276.81m
2	LEK	S.A.	USD 615.32m	USD 16.99m
3	Adamed Pharma	S.A.	USD 539.49m	USD 53.86m
4	Teva Operations Poland	sp. z o.o.	USD 527.04m	USD 77.39m
5	Aflofarm Farmacja Polska	sp. z o.o.	USD 300.66m	USD 59.18m
6	Fresenius Kabi Polska	sp. z o.o.	USD 245.99m	USD 33.23m
7	Anpharm Przedsiębiorstwo Farmaceutyczne	S.A.	USD 159.45m	USD 6.68m
8	Biofarm	sp. z o.o.	USD 142.78m	USD 34.11m
9	Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek	S.A.	USD 119.08m	USD 4.98m
10	Maco Productions Polonia	sp. z o.o.	USD 112.36m	USD 2.95m

Fastest-growing companies

#	Company	Legal form	Revenue	Y/Y growth
1	Farmak International	sp. z o.o.	USD 101.19m	+333.1% y/y
2	Zakład Farmaceutyczny Amara	sp. z o.o.	USD 47.06m	+92.4% y/y
3	Nutrition Health Institute	sp. z o.o.	USD 3.81m	+83.9% y/y
4	Vitasynth	sp. z o.o.	USD 7.35m	+80.7% y/y
5	OLAN Invest	sp. z o.o.	USD 1.81m	+66.3% y/y
6	Gemipharma	sp. z o.o.	USD 1.35m	+58.6% y/y
7	Przedsiębiorstwo Farmaceutyczne Farmapol	sp. z o.o.	USD 21.37m	+57.8% y/y
8	Nova	sp. z o.o.	USD 4.24m	+54.9% y/y
9	L-Amino Plus	sp. z o.o.	USD 1.97m	+50.5% y/y
10	Actifarm	sp. z o.o.	USD 2.14m	+49.3% y/y

Stock market

6 companies from this industry are listed.

Company	Ticker	Market	Price	Change	Market cap
Celon Pharma	CLN	GPW Main Market	PLN 18.88	0.00%	USD 254.46m
Bioton	BIO	GPW Main Market	PLN 3.80	0.00%	USD 81.57m
Synthaverse	SVE	GPW Main Market	PLN 2.79	-1.06%	USD 53.02m
Poltreg	PTG	GPW Main Market	PLN 19.55	-4.63%	USD 28.92m
Stem Cells Spin	SCS	NewConnect	PLN 0.46	0.00%	USD 4.75m
Munar Pharma	MUN	NewConnect	PLN 0.37	0.00%	USD 4.31m